Capital Research Global Investors 13D/13G Filings for Structure Therapeutics Inc. (GPCR)

Capital Research Global Investors 13D and 13G filings for Structure Therapeutics Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-11-12
12:52 pm
Purchase
2024-11-07 13G Structure Therapeutics Inc.
GPCR
Capital Research Global Investors 10,591,350
6.200%
10,591,350increase
(New Position)
Filing